Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Aileron Therapeutics will present Phase 1b trial data on low-dose LTI-03 for IPF at the 22nd International Colloquium on Lung and Airway Fibrosis

further supports the potential therapeutic effectiveness of LTI-03 for IPF through precision cut lung slices (PCLS) performed ex-vivo. Pre-clinical studies demonstrated molecular activity in IPF PCLS explants indicative of fibrosis during five days...

Blue Earth Therapeutics shares positive Phase 1 results for Lutetium (177Lu) rhPSMA-10.1 Injection, advancing its clinical development

Injection was completed in July. Early data from the trial suggests an encouraging safety profile. Radiation dosimetry performed for up to three cycles showed delivery of high tumour absorbed radiation doses relative to the dose delivered to the...

Prendio-BioProcure presents PrendioPay, simplifying procurement for life science companie

leader in procurement solutions for the life science industry, is excited to launch PrendioPay, an integrated payment platform that evolves the operational reality that most biotech companies face in their business today – separate systems,...

Disruptive Technology for Clinical Trials Summit 2024

streamline processes, and drive innovation in clinical research. From AI integration to decentralized trial platforms, innovative solutions are reshaping the way trials are designed, conducted, and analyzed for efficiency. Yet, alongside this...

HNSA-5487 reduced IgG by over 95% in a first-in-human trial, showing redosing potential

profile compared to published data from studies with other IgG-targeted therapies. These results underscore the transformational potential of HNSA-5487 to address significant unmet need across a spectrum of IgG driven diseases and conditions,...

Bruker has acquired Dynamic Biosensors, a pioneer in single-cell interaction cytometry systems, aimed at enhancing drug discovery efforts

and biotech industries, as well as in basic and medical research. The new Dynamic Biosensors heliXcyto instrument performs single-cell Interaction Cytometry (scIC) for kinetic measurements directly on cells, retaining the molecules’ native membrane...

Promega introduces the GloMax® Galaxy Bioluminescence Imager to illuminate protein dynamics in real time

of SFN 2024 to Booth #1316 to experience live demonstrations of the Glomax® Galaxy, showcasing its potential to transform research. About Promega Corporation: Promega Corporation is a leader in providing innovative solutions and technical support...

BioCare collaborates with AeroSafe Global to introduce sustainable cold chain solutions

service includes advanced reusable thermal solutions, outsourced supply chain management, a robust visibility platform, and temperature verification, all under a seamless, pay-per-turn program. About BioCare: BioCare, Inc. comprises BioCareSD, a...

LenioBio partners with ReciBioPharm to scale up ALiCE® technology and accelerate vaccine production

demonstrated ALiCE®'s ability to reliably produce vaccine-relevant proteins at small scales from cell-free DNA formats, and developed a suite of novel quality control assays to ensure the highest standards of product integrity and safety throughout...

ISCT becomes the first cell and gene therapy organization to achieve ANAB accreditation for its workforce development program

that address emerging topics such as iPSCs, CAR Ts, and advanced hands-on lab training in the coming months. More information about ISCT courses, is available here. About the ISCT Institute of Training & Development: Founded in 2023, the ISCT...

Repare Therapeutics announces promising Phase 1 data showing the effectiveness of Camonsertib in combination with radiotherapy treatment

to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA...

Doer Biologics announces the dosing of the first patient in a Phase 2 study of DR10624 for severe hypertriglyceridemia treatment.

targeting FGF21R, GLP-1R, and glucagon receptor (GCGR). Developed using Doer Bio's proprietary MultipleBody® platform technology, DR10624 was engineered to exhibit balanced activity for metabolic diseases. In non-clinical studies, DR10624 has...

EydisBio receives FDA Orphan Drug Designation for its TAK1 inhibitor to treat systemic sclerosis.

and internal organs, leading to significant morbidity and mortality. Central to the disease's pathogenesis is the transforming growth factor-β (TGF-β) pathway, with TAK1 playing a pivotal role. Activation of this pathway triggers inflammation and...

nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.

with nuBioAge, who is responsible for assembling the study and data interpretation alongside nuHx, who will be performing the ongoing assessments for the patients participating in the study. Patients will be recruited and supplied with medication...

Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.

companies. "We are excited to unveil our Phase 2 study plan, bringing us one step closer to a potentially transformative therapy for breast cancer patients," said Dr. Amit Kumar, Chairman and CEO of Anixa Biosciences. "By targeting treatment rather...

Merz Aesthetics launches Ultherapy PRIME, the next generation of nonsurgical skin lifting treatments

a truly personalized and long-lasting* lift of the skin in one session with zero downtime. The Ultherapy PRIME platform is the evolution of Ultherapy®, which has been recognized as the Gold Standard for nonsurgical lifting and skin tightening due...

Restore Hyper Wellness has partnered with MECOTEC to enhance their offerings in cryotherapy solutions.

focuses on achieving total balance, energy, and proactive healing, with services designed to enhance the body's natural performance. Restore's nationwide presence of 225+ studios continues to grow rapidly, fueled by its commitment to helping people...

Biotech Congress 2024

experiences and research results on all aspects of Biotechnology, Bioengineering. It is also providing participants a platform for the dissemination and discussion of recent innovation and the most recent and exciting developments in Biotechnology,...

2nd Global Summit on Pharmaceutical and Medicinal Chemistry 2024

interdisciplinary approaches in Pharmaceutical and Medicinal Chemistry. Moreover, the conference offers a valuable platform to create new contacts in the field of Pharmaceutical and Medicinal chemistry by providing valuable networking time for you...

Netstal showcases a medtech application with quality monitoring at Fakuma

reproducibility and purity in the medical production environment. The enormous control accuracy is ensured by high-performance mechanics, high-precision measurement technology and sophisticated control technology. The latest Axos 9 control...